The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.89
Bid: 3.60
Ask: 4.18
Change: 0.00 (0.00%)
Spread: 0.58 (16.111%)
Open: 3.89
High: 0.00
Low: 0.00
Prev. Close: 3.89
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Subscription Update

3 Mar 2022 12:56

RNS Number : 5580D
Tanfield Group PLC
03 March 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain

 

 

Tanfield Group Plc

("Tanfield" or the "Company")

 

Loan Subscription Update

 

 

The Board of Tanfield (the "Board") is pleased to update the market with respect to additional loans put in place to fund the Company's ongoing legal proceedings in relation to its investment in Snorkel International Holdings LLC ("Snorkel"), the aerial work platform business, and other day to day costs.

 

Investment Background

 

· Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme Manufacturing LLC ("Xtreme") (the "Contemplated Transaction"), a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

· The Snorkel investment is valued at £19.1m. The outcome of the US and UK Proceedings referenced below could have an impact on this valuation.

 

· On 22 October 2019, the Company announced that it had received a Summons and Complaint, filed in Nevada (the "US Proceedings") by subsidiaries of Xtreme, relating to the Contemplated Transaction.

 

· On 24 October 2019, the Company announced it had become necessary to issue and serve a claim in the English High Court against Ward Hadaway (the "UK Proceedings"), the solicitor acting for the Company at the time of the Contemplated Transaction, in order to fully protect the Company's rights pending the outcome of the US Proceedings.

 

· On 26 February 2021, Ward Hadaway were granted permission to join Foulston Siefkin LLP ("Foulston Siefkin"), Tanfield's US based law firm who were retained in 2013 to draft the documents governed by US law relating to the Contemplated Transaction, into the UK Proceedings. As a result, the Company amended its claim to include Foulston Siefkin as a second defendant.

 

 

Loan Subscription

 

Further to the update on 3 June 2021, in which the Company announced that the second loan note instrument (the "Second Loan") of up to £1m had subscriptions totalling £950,000, and the update on 30 March 2020, in which the Company announced the first loan note instrument (the "First Loan") of up to £700,000, with £500,000 initially being subscribed to, the Board is pleased to announce that an additional £125,000 of the First Loan has now been subscribed to, taking the total First Loan subscription value to £625,000. The additional First Loan (the "Additional Loan") will be used for providing ongoing funding for the US and UK Proceedings and other day to day costs.

 

The Additional Loan is unsecured and carries annual interest of 10% which is to accrue and is repayable on the earlier of (i) 28 February 2025 or (ii) receipt of sufficient funds relating to either the US or UK Proceedings. Should repayment take place prior to 28 February 2025, a 20% early redemption premium shall apply.

 

A number of existing shareholders have subscribed to the Additional Loan of £125,000, which constitutes a related party transaction under Rule 13 of the AIM Rules as a result of OTK Holding A/S and Zoar Invest Aps, which each hold approximately 14% of the issued shares of the Company, subscribing £50,000 each to the Additional Loan. The Directors of the Company, having consulted with WH Ireland Limited, the Company's nominated adviser, consider the terms of the transaction to be fair and reasonable in so far as shareholders are concerned.

 

Following discussions with the existing shareholders, the Board are of the opinion that further loan funding may be necessary to ensure that the Company can continue to protect its investment in Snorkel.

 

The Board believe that a positive outcome to either or both of the US Proceedings and UK Proceedings is a reasonable expectation, and the Company will continue to vigorously defend and advance its position in both proceedings, whilst continuing to seek advice. 

 

Further updates will be provided to Shareholders as and when appropriate.

 

 

 

For further information:

 

Tanfield Group Plc 020 7220 1666

Daryn Robinson  

 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Ben Good 020 7220 1666

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKNBPBBKDNNK
Date   Source Headline
28th Apr 20082:57 pmRNSExercise of options
28th Apr 20082:51 pmRNSHolding(s) in Company
22nd Apr 20087:01 amRNSFinal Results
15th Apr 20087:00 amRNSNew product launch
19th Mar 200811:38 amRNSNotice of Results
14th Mar 200812:53 pmRNSHolding(s) in Company
14th Mar 200812:51 pmRNSHolding(s) in Company
12th Mar 20084:32 pmRNSHolding(s) in Company
7th Mar 20089:30 amRNSHolding(s) in Company
29th Feb 200811:21 amRNSHolding(s) in Company
28th Feb 20082:48 pmRNSHolding(s) in Company
25th Feb 20083:05 pmRNSHolding(s) in Company
25th Feb 20087:01 amRNSEnova Confirms Order
11th Feb 20089:25 amRNSHolding(s) in Company
14th Jan 20087:00 amRNSStmnt re Share Price Movement
9th Jan 20083:54 pmRNSHolding(s) in Company
18th Dec 20077:01 amRNSPre-Close Trading Update
11th Dec 200710:45 amRNSHolding(s) in Company
28th Nov 200712:59 pmRNSHolding(s) in Company
21st Nov 20071:02 pmRNSHolding(s) in Company
16th Nov 200710:29 amRNSHolding(s) in Company
8th Nov 200710:40 amRNSHolding(s) in Company
6th Nov 200710:04 amRNSHolding(s) in Company
26th Oct 200711:56 amRNSHolding(s) in Company
10th Oct 200711:07 amRNSHolding(s) in Company
8th Oct 200711:53 amRNSHolding(s) in Company
1st Oct 20072:10 pmRNSResult of AGM
25th Sep 20077:03 amRNSInterim Results
4th Sep 20075:36 pmRNSHolding(s) in Company
23rd Aug 200712:06 pmRNSHolding(s) in Company
16th Aug 20077:00 amRNSNotice of Interim Results
15th Aug 20073:28 pmRNSAIM Rule 26
10th Aug 20075:31 pmRNSHolding(s) in Company
6th Aug 200710:04 amRNSHolding(s) in Company
1st Aug 20079:01 amRNSAcquisition Completion
31st Jul 20071:09 pmRNSHolding(s) in Company
26th Jul 20077:01 amRNSAcquisition Update
23rd Jul 200712:15 pmRNSTrading Statement
23rd Jul 200712:15 pmRNSEGM Statement
17th Jul 20072:06 pmRNSHolding(s) in Company
9th Jul 20074:03 pmRNSHolding(s) in Company
28th Jun 20072:43 pmRNSHolding(s) in Company
28th Jun 20079:26 amRNSAnnual Report and Accounts
28th Jun 20077:04 amRNSAcquisition & Placing
27th Jun 200711:17 amRNSRe: Press Speculation
21st Jun 20072:19 pmRNSHolding(s) in Company
20th Jun 20077:02 amRNSEnova Confirms Order
13th Jun 20077:01 amRNSContract Win
7th Jun 200710:37 amRNSHolding(s) in Company
31st May 200712:40 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.